2-chloro-n(6)cyclopentyladenosine has been researched along with Hibernation, Myocardial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lasley, RD; Mentzer, RM; Narayan, P | 1 |
Burgdorf, C; Jain, D; Katus, HA; Kurz, T; Richardt, D; Richardt, G; Seyfarth, M | 1 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Hibernation, Myocardial
Article | Year |
---|---|
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines | 2001 |
Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning.
Topics: Adenosine; Analysis of Variance; Animals; Brimonidine Tartrate; Electric Stimulation; Enzyme Inhibitors; Male; Myocardial Stunning; Myocardium; Norepinephrine; Perfusion; Phenethylamines; Phenylisopropyladenosine; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Sympathetic Nervous System; Theophylline; Time Factors; Xanthines | 2001 |